A UNC Chapel Hill Ph.D. graduate who is the founder and CEO of Koya Medical, a team dedicated to transforming chronic lymphatic and venous disease. Andy also serves as Chairman and board director with an eye-care and urology health venture. Previously, he led Oculeve, a first-in-class healthcare venture funded by NEA, KPCB, and Versant to treat ocular disorders with a revolutionary neuromodulation platform. Oculeve was acquired by Allergan Plc.

Brian Miller, M.D., MBA, MPH is an Assistant Professor of Medicine and Business (courtesy) at the Johns Hopkins University, where he is a practicing hospitalist, health policy researcher, and health policy analyst. He is a consultant to the FTC Bureau of Consumer Protection on health insurance and is a member of the Medicare Evidence Development & Coverage Advisory Committee.

Peter C. Johnson, M.D., is the president and CEO of Scintellix, LLC, a biomedical technology consulting company in Raleigh, NC and the VP, R&D and Medical and Scientific Affairs, Vancive Medical Technologies – an Avery Dennison business. 

Dr. Burclaff Joined the department in 2019 as a Postdoctoral Research Fellow with Dr. Scott T Magness. He became a Research Assistant Professor in 2022 and is actively involved in determining how proliferative populations within the human intestinal crypt control their proliferation and cell fate decisions, with a focus on transcriptional regulators of epithelial metabolism.